For the purpose of evaluating the efficacy, safety and usefulness of ceftriaxone (CTRX), a cephem antibiotic, in respiratory tract infections, a well-controlled comparative study was carried out with cefotaxime (CTX) for a reference.
One (1) gm of either CTRX or CTX was administered by drip infusion twice a day for 7 to 14 days in principle into patients with chronic bronchitis and diffuse panbronchiolitis aggravated with infections, chronic respiratory diseases accompanied with infections in the lower respiratory tract like bronchiectasis, bronchial asthma, pulmonary emphysema, pulmonary fibrosis, obsolete pulmonary tuberculosis, lung cancer, etc. and bacterial pneumonia.
Results were as follows:
1) Clinical efficacy: The efficacy rate was 81%(100/124) with CTRX and 74%(94/127) with CTX, with no statistically significant difference between the two drugs. The efficacy rate in the moderately infected patients was 81%(54/67) with CTRX and 62%(37/60) with CTX, CTRX being significantly superior to CTX.If cases infected with P. aerugirrosa were excluded, CTRX was higher in efficacy than CTX.
2) Bacteriological effects: The bacterial eradication occurred in 35 patients out of 44 (80%) with CTRX and in 42 out of 54 (78%) with CTX, with no statistically significant difference. There was no significant difference in efficacy between the two, whether according to strains of isolates or types of infections (single or mixed).
3) Adverse reactions: The incidence of adverse reactions was 10.5%(14/133) to CTRX and 6.3%(9/143) to CTX, no statistically significant difference being noticed. The incidence of skin rash was significantly higher with CTRX. In the clinical laboratory test, abnormal signs were observed in 37 out of 130 (28.5%) with CTRX and in 36 out of 137 (26.3%) with CTX, no significant difference being detected.
4) Usefulness: CTRX was evaluated to be very useful in 3 out of 133, useful in 94, slightly useful in 13 and useless in 20. There were 3 unevaluable cases.CTX was very useful in 2 out of 143, useful in 90, slightly useful in 14 and useless in 28. Evaluation was impossible in 9 cases.There was no significant difference in usefulness between CTRX and CTX.
5) Conclusion: From the above, CTRX was considered to be clinically very useful for the treatment of infections of the lower respiratory tract like chronic respiratory tract infections and pneumonia.
View full abstract